Mitchell Mutz

Mitchell Mutz, Ph.D., is a seasoned professional in the biotechnology industry with extensive experience in investments, company building, and scientific research. Currently serving as Senior Principal at Samsara BioCapital since July 2025, Mutz previously held the position of Entrepreneur Partner at Vivo Capital, where involvement included sourcing deals and building companies like EpiBiologics and Vellum Biotechnology. Previous roles include Partner at Codon Capital and Senior Investment Director at Roche Venture Fund, where Mutz managed significant investments, leading to successful acquisitions. Mutz co-founded and served as President and Chief Scientific Officer at Amplyx Pharmaceuticals, which focused on innovative therapies for infectious diseases and was acquired by Pfizer in 2021. With a strong educational background in chemistry and music performance from prestigious institutions, Mutz has a rich history in scientific research and development, contributing to advancements in the field.